131 related articles for article (PubMed ID: 18415673)
1. Wake up and smell the coffee: yet another no go for cardiac patients? : editorial to "caffeinated coffee blunts the myocardial protective effects of statins against ischemia-reperfusion injury in the rat" by Ye et al.
Riksen NP; Hausenloy DJ; Yellon DM
Cardiovasc Drugs Ther; 2008 Aug; 22(4):257-9. PubMed ID: 18415673
[No Abstract] [Full Text] [Related]
2. Caffeinated coffee blunts the myocardial protective effects of statins against ischemia-reperfusion injury in the rat.
Ye Y; Abu Said GH; Lin Y; Manickavasagam S; Hughes MG; McAdoo DJ; Perez-Polo RJ; Birnbaum Y
Cardiovasc Drugs Ther; 2008 Aug; 22(4):275-82. PubMed ID: 18327703
[TBL] [Abstract][Full Text] [Related]
3. Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin.
Rosanio S; Ye Y; Atar S; Rahman AM; Freeberg SY; Huang MH; Uretsky BF; Birnbaum Y
Cardiovasc Drugs Ther; 2006 Feb; 20(1):27-36. PubMed ID: 16435070
[TBL] [Abstract][Full Text] [Related]
4. Aspirin before reperfusion blunts the infarct size limiting effect of atorvastatin.
Birnbaum Y; Lin Y; Ye Y; Martinez JD; Huang MH; Lui CY; Perez-Polo JR; Uretsky BF
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2891-7. PubMed ID: 17277020
[TBL] [Abstract][Full Text] [Related]
5. Effect of atorvastatin on expression of IL-10 and TNF-alpha mRNA in myocardial ischemia-reperfusion injury in rats.
Sun YM; Tian Y; Li X; Liu YY; Wang LF; Li J; Li ZQ; Pan W
Biochem Biophys Res Commun; 2009 May; 382(2):336-40. PubMed ID: 19275881
[TBL] [Abstract][Full Text] [Related]
6. Effect of atorvastatin treatment on isoproterenol-induced myocardial infarction in rats.
Trivedi CJ; Balaraman R; Majithiya JB; Bothara SB
Pharmacology; 2006; 77(1):25-32. PubMed ID: 16567950
[TBL] [Abstract][Full Text] [Related]
7. Effects of acute and chronic atorvastatin on cardioprotection of ischemic postconditioning in isolated rat hearts.
Fan Y; Yang S; Cao Y; Huang Y
Cardiovasc Ther; 2013 Aug; 31(4):187-92. PubMed ID: 22954178
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin post-conditioning attenuates myocardial ischemia reperfusion injury via inhibiting endoplasmic reticulum stress-related apoptosis.
Xia JG; Xu FF; Qu Y; Song DG; Shen H; Liu XH
Shock; 2014 Oct; 42(4):365-71. PubMed ID: 25004060
[TBL] [Abstract][Full Text] [Related]
9. Statins to prevent cardiovascular events in hypertensive patients. The ASCOT-LLA study.
Osende JI; Ruiz-Ortega M; Blanco-Colio LM; Egido J
Nephrol Dial Transplant; 2004 Mar; 19(3):528-31. PubMed ID: 14767002
[No Abstract] [Full Text] [Related]
10. Reduction of infarct size by short-term pretreatment with atorvastatin.
Birnbaum Y; Ashitkov T; Uretsky BF; Ballinger S; Motamedi M
Cardiovasc Drugs Ther; 2003 Jan; 17(1):25-30. PubMed ID: 12843684
[TBL] [Abstract][Full Text] [Related]
11. Atorvastatin treatment of rats with ischemia-reperfusion injury improves adipose-derived mesenchymal stem cell migration and survival via the SDF-1α/CXCR-4 axis.
Cai A; Qiu R; Li L; Zheng D; Dong Y; Yu D; Huang Y; Rao S; Zhou Y; Mai W
PLoS One; 2013; 8(12):e79100. PubMed ID: 24312447
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin reduces myocardial fibrosis in a rat model with post-myocardial infarction heart failure by increasing the matrix metalloproteinase-2/tissue matrix metalloproteinase inhibitor-2 ratio.
An Z; Yang G; He YQ; Dong N; Ge LL; Li SM; Zhang WQ
Chin Med J (Engl); 2013; 126(11):2149-56. PubMed ID: 23769575
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury.
Birnbaum Y; Ye Y; Rosanio S; Tavackoli S; Hu ZY; Schwarz ER; Uretsky BF
Cardiovasc Res; 2005 Feb; 65(2):345-55. PubMed ID: 15639473
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.
Ajamieh H; Farrell G; Wong HJ; Yu J; Chu E; Chen J; Teoh N
J Gastroenterol Hepatol; 2012 Aug; 27(8):1353-61. PubMed ID: 22432744
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of contractile dysfunction by atorvastatin after intestinal ischemia reperfusion injury in rats.
Ozacmak VH; Sayan H; Igdem AA; Cetin A; Ozacmak ID
Eur J Pharmacol; 2007 May; 562(1-2):138-47. PubMed ID: 17335801
[TBL] [Abstract][Full Text] [Related]
16. Lipophilic HMG-CoA reductase inhibitors increase myocardial stunning in dogs.
Satoh K; Ichihara K
J Cardiovasc Pharmacol; 2000 Feb; 35(2):256-62. PubMed ID: 10672858
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective effect of rosuvastatin in vivo is dependent on inhibition of geranylgeranyl pyrophosphate and altered RhoA membrane translocation.
Bulhak A; Roy J; Hedin U; Sjöquist PO; Pernow J
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H3158-63. PubMed ID: 17322412
[TBL] [Abstract][Full Text] [Related]
18. Journal Watch: evidence that Atorvastatin reduces the risk of stroke and myocardial infarction in patients with type 2 diabetes, but with no evidence of dyslipidaemia.
Gangaidzo IT
Cent Afr J Med; 2005; 51(11-12):125-6. PubMed ID: 17447346
[No Abstract] [Full Text] [Related]
19. The role of eNOS, iNOS, and NF-kappaB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin.
Ye Y; Martinez JD; Perez-Polo RJ; Lin Y; Uretsky BF; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H343-51. PubMed ID: 18469150
[TBL] [Abstract][Full Text] [Related]
20. SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.
Strande JL; Hsu A; Su J; Fu X; Gross GJ; Baker JE
Basic Res Cardiol; 2007 Jul; 102(4):350-8. PubMed ID: 17468933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
